VanEck Associates’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Sell |
6,541
-857
| -12% | -$16K | ﹤0.01% | 1291 |
|
|
2025
Q1 | $142K | Buy |
7,398
+2,497
| +51% | +$47.9K | ﹤0.01% | 1253 |
|
|
2024
Q4 | $177K | Buy |
4,901
+1,074
| +28% | +$38.8K | ﹤0.01% | 1239 |
|
|
2024
Q3 | $123K | Sell |
3,827
-324
| -8% | -$10.4K | ﹤0.01% | 1242 |
|
|
2024
Q2 | $167K | Sell |
4,151
-1,947
| -32% | -$78.3K | ﹤0.01% | 1204 |
|
|
2024
Q1 | $216K | Buy |
6,098
+198
| +3% | +$7.01K | ﹤0.01% | 1169 |
|
|
2023
Q4 | $175K | Buy |
5,900
+467
| +9% | +$13.9K | ﹤0.01% | 1179 |
|
|
2023
Q3 | $113K | Buy |
5,433
+280
| +5% | +$5.82K | ﹤0.01% | 1218 |
|
|
2023
Q2 | $126K | Buy |
5,153
+1,069
| +26% | +$26.1K | ﹤0.01% | 1212 |
|
|
2023
Q1 | $166K | Sell |
4,084
-113
| -3% | -$4.59K | ﹤0.01% | 1192 |
|
|
2022
Q4 | $189K | Buy |
4,197
+3,366
| +405% | +$152K | ﹤0.01% | 1112 |
|
|
2022
Q3 | $40K | Buy |
+831
| New | +$40K | ﹤0.01% | 1279 |
|